For more information about this brand, click here.

For more information about this brand, click here.

Bristol-Myers Squibb has also done a big oncolytic virus deal, acquiring rights late last year to an “armed virus” targeting cancer from the UK biotech, PsiOxus Therapeutics, worth almost $900 ...

This advertisement has not loaded yet, but your article continues below. The franchisee of the Second Cup locations at the Jewish General Hospital was filmed telling pro-Israel protesters: 'The ...